Skip to main content
Log in

The desirability and feasibility of economic studies of drugs post-launch

  • Editorial
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Claxton K (1999) Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals. Health Econ 8:269–274

    Article  PubMed  Google Scholar 

  2. Mason A, Drummond MF, Towse A (2006) Economic post-launch studies: matching the desirable with the feasible. OHE monograph. Office of Health Economics: London (http://www.ohe.org)

    Google Scholar 

Download references

Conflict of interest:

No information supplied.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Drummond.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drummond, M., Mason, A. & Towse, A. The desirability and feasibility of economic studies of drugs post-launch. Eur J Health Econ 7, 5–6 (2006). https://doi.org/10.1007/s10198-006-0337-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-006-0337-2

Navigation